Abstract
The value of Tissue Inhibitor of MetalloProteinase-1 (TIMP-1) as a biomarker in patients with gastric cancer (GC) is widely debated. The aim of this review is to evaluate available literature describing the association between levels of TIMP-1 in tumor tissue and/or blood and the prognosis of patients suffering from GC.
Originalsprog | Engelsk |
---|---|
Tidsskrift | Scandinavian Journal of Gastroenterology |
Vol/bind | 48 |
Udgave nummer | 8 |
Sider (fra-til) | 899-905 |
Antal sider | 7 |
ISSN | 0036-5521 |
DOI | |
Status | Udgivet - aug. 2013 |